Rhythm Pharmaceuticals Inc.

NASDAQ: RYTM
Share price (3/25/25): $52.91
Market cap (3/25/25): $3.345 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2 2024 – amended

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus with selling stockholder info

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Ownership Filter

German Christopher Paul

News Filter

Reacquires Licensing Rights to IMCIVREE® (Setmelanotide) in China With Termination of Agreement With RareStone Ltd

Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones

Reports Third Quarter 2024 Financial Results and Business Update

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC